Atlas Trials

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Clinical trial NCT05950087 · RECRUITING

Trial details

NCT number
NCT05950087
Sponsor
Guizhou Provincial People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Locally Advanced Cervical Cancer
Start date
2022-11-01
Primary completion
2024-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.